The Lift Line

The state is funding the expansion of AYUSH colleges with one hand and denying their permissions with the other, and the expansion is winning.

Why This Editorial Matters for Your Exam

This is a clean GS2 regulation case: a sector growing on public subsidy, a documented twenty-year quality deficit, a rebuilt regulator that detects failures without deterring them, and an incentive problem the courts have named. Health-education regulation questions recur, and this gives you a non-allopathic variant most aspirants will not have prepared.

GS Paper 2: Government policies and interventions; issues relating to development and management of health and education; statutory and regulatory bodies.

Concept Meaning Why it is testable
NCISM Statutory regulator of Ayurveda, Unani, Siddha and Sowa-Rigpa education under the NCISM Act, 2020 Replaced the Central Council of Indian Medicine in a 2020 rebuild
National Commission for Homoeopathy Separate statutory regulator for homoeopathy education under its own 2020 Act Homoeopathy is not under the NCISM, a standard confusion
AYURGYAN Central scheme funding AYUSH education, training, research and capacity-building Its allocation grew nearly sixfold between 2021 and 2024

Background and Context

The expansion. Government data for 2024 put 86 per cent of Ayurveda colleges and 85 per cent of homoeopathy colleges in the non-government sector. Between 2021 and 2024, permitted seats rose 43 per cent and total admission capacity 25 per cent, while the Centre’s AYURGYAN allocation increased nearly sixfold.

The pre-existing deficit. In a 2005 audit, the Comptroller and Auditor General found insufficient hospital beds, outpatient services and staff widespread among homoeopathy colleges, with bed occupancy from 1 per cent to 71 per cent. A 2020 article in the Journal of Ayurveda and Integrative Medicine reported teaching staff shortfalls exceeding 50 per cent of the prescribed standard in many institutions.

The regulatory rebuild. The NCISM Act, 2020 and the National Commission for Homoeopathy Act, 2020 replaced the old central councils dating from the 1970s. The new commissions inspect, grade, and grant or deny permissions to colleges.

The enforcement record. As of late August 2026, the NCISM listed 17 Ayurveda colleges, all private, whose permissions it had denied, several for non-compliance with the inspection process. The National Commission for Homoeopathy has given 41 per cent of all homoeopathy colleges its lowest grade, including nearly half of all private institutions.

The Analysis

1. The incentive problem is structural, not episodic. A private college’s revenue scales with intake while its costs scale with faculty and laboratories, so the profitable configuration is maximum students on minimum capacity. The Karnataka High Court said as much in the Hillside Ayurveda Medical College case (2023): institutions are “often guilty of admitting excess students for financial gains”. A regulator that inspects annually is playing defence against an incentive that operates daily.

2. Detection without deterrence is the actual finding. Denied permissions and low grades show the commissions are working, and the editorial credits them for it. But 41 per cent of a sector in the lowest grade is not a regulator failing to see the problem; it is a sector finding the consequences of the problem bearable. That distinction, between a monitoring failure and a sanctions failure, is worth writing into any regulation answer.

3. Public money is on both sides of the ledger. AYURGYAN grew nearly sixfold across exactly the window in which seats surged. When subsidy accelerates expansion faster than inspection can verify it, the state is underwriting the risk it is supposed to police. Conditioning funds on sustained quality grades is the obvious coupling, and its absence is the gap.

4. The comparison with allopathic education sharpens the stakes. The editorial’s contrast is precise: for MBBS colleges the worry is whether graduates are prepared for evidence-based practice; for AYUSH the worry extends to the quality of training and to what is being trained. A weak college in either stream produces a licensed practitioner the public cannot easily evaluate, which is why education quality here is a public health question, not a consumer choice question.

5. Non-compliance with inspection is the tell. Several denials were not for failing an inspection but for not complying with the inspection process itself. Where being inspected is the thing avoided, self-reported data in the sector deserves no benefit of the doubt, and unannounced verification, including of faculty rolls against actual presence, becomes the load-bearing reform.

Data and Institutions Vault

Prelims-grade facts:

The expansion:

  • 86 per cent of Ayurveda colleges and 85 per cent of homoeopathy colleges were non-government in 2024.
  • Permitted seats rose 43 per cent and total admission capacity 25 per cent between 2021 and 2024.
  • The Centre’s AYURGYAN allocation for AYUSH education and research grew nearly sixfold in the same window.

The regulators:

  • The National Commission for Indian System of Medicine regulates Ayurveda, Unani, Siddha and Sowa-Rigpa education under the NCISM Act, 2020.
  • Homoeopathy education is regulated separately by the National Commission for Homoeopathy under its own 2020 Act.
  • The two 2020 Acts replaced the Central Council of Indian Medicine and the Central Council of Homoeopathy.
  • The Ministry of Ayush was created as a full ministry in November 2014.

The quality record:

  • A 2005 CAG audit found bed occupancy in homoeopathy colleges ranging from 1 per cent to 71 per cent.
  • A 2020 Journal of Ayurveda and Integrative Medicine study reported faculty shortfalls exceeding 50 per cent in many institutions.
  • As of late August 2026, the NCISM listed 17 Ayurveda colleges, all private, with permissions denied.
  • The National Commission for Homoeopathy has placed 41 per cent of all homoeopathy colleges in its lowest grade.
  • In the Hillside Ayurveda case (2023), the Karnataka High Court noted colleges admitting excess students for financial gain.

⚠️ Watch the trap: The NCISM does not regulate homoeopathy. Homoeopathy has its own commission under a separate 2020 Act, and yoga and naturopathy sit under neither Act. A question pairing “NCISM” with “homoeopathy” is testing exactly this.

The Debate

FOR (tighten now): The deficits are twenty years documented, the incentive to over-admit is judicially recognised, and expansion is compounding on public subsidy. Waiting for proof that the boom amplified the problems means certifying a decade of under-trained practitioners first.

AGAINST (the system is working): Denials, inspections and low grades are what functioning regulation looks like. Private capacity is how every Indian professional discipline grew, and throttling supply raises seat prices without adding a single teacher.

Balanced verdict: The editorial itself concedes it is premature to say expansion has amplified the deficits, and that caution is correct. But regulation exists precisely for the case where waiting for proof is itself the harm. The defensible position is sequencing: harden inspection integrity and couple funding to quality now, before the next expansion cycle, and treat the evidence-base question as a separate, standing obligation.

How to Think About This

When you meet a regulation question, separate three failures that look alike: the regulator cannot see the problem, the regulator can see it but its sanctions do not bite, and the regulator’s own principal, the state, is subsidising the behaviour it polices. They have different remedies, and most weak answers propose remedy one for failure two or three. This editorial is a worked example of failures two and three coexisting with genuinely active monitoring.

Diagram-in-Words

AYURGYAN subsidy nearly sixfold rise 2021-24 Private intake incentive revenue scales with students Rapid expansion seats up 43 per cent Regulator detects, not deters 17 denials; 41 per cent lowest grade Harden inspections verify faculty exist and teach Condition the subsidy public money follows grades Cap intake to capacity seats follow verified faculty
Subsidy and private incentive push in the same direction; inspection pushes back alone. The reforms all work by coupling something to verified quality: money, permission or intake.

Takeaway Box

Lift line: The state is funding the expansion of AYUSH colleges with one hand and denying their permissions with the other, and the expansion is winning.

Prelims hooks: 86 per cent of Ayurveda and 85 per cent of homoeopathy colleges non-government in 2024; seats up 43 per cent between 2021 and 2024; AYURGYAN allocation up nearly sixfold; NCISM Act, 2020 covers Ayurveda, Unani, Siddha and Sowa-Rigpa; homoeopathy under the separate National Commission for Homoeopathy Act, 2020; 2005 CAG audit; 41 per cent of homoeopathy colleges in the lowest grade; Ministry of Ayush created November 2014.

Mains keywords: regulatory capacity, incentive alignment, detection versus deterrence, conditional funding, quality assurance in professional education.

Ethics and interview angle: A student who pays full fees at a college later denied permission has been failed by the college, the regulator and the subsidy that built it. Who owes the remedy, and in what order?

PYQ linkage: Connects to past UPSC Mains questions on regulatory bodies in higher education, public health system capacity, and government intervention in professional education markets.

Sources: The Hindu

Source: AYUSH Colleges Are Multiplying Faster Than Anyone Is Checking Their Quality — Ujiyari.com | Free UPSC & State PCS Editorial Analysis